Menu

Scientific Publication

February 24, 2022

©PatenSee

Related Posts

Back To Top
© Patensee 2024
Powered by: SPInc

PatenSee is an emerging, clinical-stage, startup company with a novel, contactless imaging device for the early detection of vascular access complications in hemodialysis patients. The technology uses a unique data stream to mimic a best practice, physical examination. PatenSee recently signed a clinical collaboration agreement with Fresenius Medical Care, following the completion of a POC clinical trial with very promising results.


PatenSee is a portfolio company of MEDX Xelerator, a medical device incubator backed by Boston Scientific, Sheba Medical Center, MEDX Ventures Group, Consensus Business Group (CBG), West Pharmaceuticals and The Portland Trust.